Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP: Inpatient Varenicline for Smoking Cessation
NCT01141855Phase 3Completed
- Start
- May 2008
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of varenicline in Tobacco Use Disorder (TUD) (2 arms). Primary endpoint: Smoking abstinence at 1 year. Started May 2008; status: completed.
02
Drugs
varenicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01141855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141855.